Found: 6
Select item for more details and to access through your institution.
Multi-Target Directed Ligands (MTDLs) Binding the σ 1 Receptor as Promising Therapeutics: State of the Art and Perspectives.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6359, doi. 10.3390/ijms22126359
- By:
- Publication type:
- Article
MRP1-Collateral Sensitizers as a Novel Therapeutic Approach in Resistant Cancer Therapy: An In Vitro and In Vivo Study in Lung Resistant Tumor.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 9, p. 3333, doi. 10.3390/ijms21093333
- By:
- Publication type:
- Article
PB28, the Sigma-1 and Sigma-2 Receptors Modulator With Potent Anti–SARS-CoV-2 Activity: A Review About Its Pharmacological Properties and Structure Affinity Relationships.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.589810
- By:
- Publication type:
- Article
σ 2 Receptor and Its Role in Cancer with Focus on a MultiTarget Directed Ligand (MTDL) Approach.
- Published in:
- Molecules, 2021, v. 26, n. 12, p. 3743, doi. 10.3390/molecules26123743
- By:
- Publication type:
- Article
Multifunctional thiosemicarbazones targeting sigma receptors: in vitro and in vivo antitumor activities in pancreatic cancer models.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 6, p. 1307, doi. 10.1007/s13402-021-00638-5
- By:
- Publication type:
- Article
A conformational rearrangement of the SARS-CoV-2 host protein sigma-1 is required for antiviral activity: insights from a combined in-silico/in-vitro approach.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39662-w
- By:
- Publication type:
- Article